Login / Signup

How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer.

Pirmin SchlickeChristina KuttlerChristian Schumann
Published in: Theoretical biology & medical modelling (2021)
The mathematical model presented in this study gives insights in how this could be achieved, taking into account different treatment possibilities and therefore being able to compare therapy schedules for individual patients with different clinical parameters. The framework was tested on three patients with non-small cell lung cancer, one of the deadliest types of cancer worldwide, and clinical history including platinum-based chemotherapy and PD-L1-targeted immunotherapy. Results yield promising insights into the framework to establish methods to quantify effects of different therapy methods and prognostic features for individual patients already at stage of primary diagnosis.
Keyphrases
  • end stage renal disease
  • small cell lung cancer
  • squamous cell carcinoma
  • chronic kidney disease
  • stem cells
  • mesenchymal stem cells
  • replacement therapy
  • drug delivery
  • bone marrow
  • smoking cessation